A series of Biginelli adducts bearing different substituents at C-4 position were synthesized by using psulfonic acid calix[4]arene as a catalyst. The in vitro potential to scavenge reactive nitrogen/oxygen species (RNS and ROS) and the ability to inhibit cancer cells growth were then investigated. Four adducts were found to be potent scavengers of 2,2-diphenyl-1-picrylhydrazyl (RNS) and/or superoxide anion (ROS) radicals. The antiproliferative activity against cancer cells was disclosed for the first time for 16 monastrol analogs. The capacity of all compounds to inhibit cancer cells growth was dependent on the histological origin of cells, except for BA24, which was highly active against all cell lines. BA20 and BA33 were as potent as the reference drug doxorubicin against adriamycin-resistant ovarian and prostate cancer cells, respectively. These results highlight some monastrol analogs as lead compounds for the design of new free radical scavengers and anticancer agents.
Introduction
A multicomponent reaction (MCR) is defined as the process in which three or more reactants are combined in a single step to form a product that incorporates structural characteristics of each reagent. Besides providing structures more complex than the starting materials, MCRs offer simplicity and efficiency to synthetic approaches. 1, 2 Despite the spectacular growth of combinatorial chemistry in the 80s and 90s, only few MCRs have been developed by companies (especially pharmaceutical industries) or research laboratories. [1] [2] [3] [4] The Biginelli reaction, discovered by Pietro Biginelli in 1893, is an MCR that involves the cyclocondensation of acetoacetic esters, aromatic aldehydes and (thio)urea. 5 The products of this three-component synthesis were identified as 3,4-dihydropyrimidin-2(1H)-ones (DHPMs). Special attention was given to this type of MCR in the late 20th century with the discovery of the potential biological activities of compounds bearing a DHPM moiety. [6] [7] [8] [9] Indeed, batzeladine B (1) (Fig. 1) , a marine natural product isolated from Batzella sp. was found to inhibit the binding of HIV envelop protein gp-120 to human CD4 cells. 10 Monastrol (BA2) ( Fig. 1 ) was identified as a potent anticancer agent due to its ability to freely cross cell membrane. 11 Such Biginelli adduct affects mitosis independently of tubulin binding, a mechanism of action presented by drugs such natural taxanes, vinca alkaloids and epothilones. [12] [13] [14] [15] [16] Other DHPMs, such as SQ 32926 (3) and SQ 32547 (4) ( Fig. 1) , were reported to possess antihypertensive properties. 17, 18 The antioxidant properties of DHPMs were also described by Stefani's 19 and Kumar's 8 groups. Adducts 5 and 6 ( Fig. 1 ) were able to scavenge 46% of reactive oxygen species (ROS) produced in mice liver, when used at 100 lM. 19 The DHPMs 7 and 8 ( Fig. 1 ) were able to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals by 50% when employed at 1 mM. 8 The diverse biological profile exhibited by Biginelli adducts brought new perspectives for the development of new drugs based on DHPM core. Herein, we report the synthesis of twenty-six Biginelli adducts and their potential as scavengers of reactive nitrogen and oxygen species (RNS and ROS, respectively) and inhibitors of cancer cells proliferation.
Results and discussion

Synthesis of Biginelli adducts
Twenty-six Biginelli adducts (BA2, BA9-BA33; Table 1 ) were synthesized from MCRs that consisted of aldehydes, ethyl acetoacetate, (thio)urea and p-sulfonic acid calix [4] arene as a catalyst according to an approach developed by our group. 20 DHPMs derived from aromatic aldehydes bearing electron-donating or electron-withdrawing groups were obtained in good yields. Nonaromatic aldehydes, however, were less reactive, affording moderate yields of Biginelli adducts. Urea furnished better yields when compared with thiourea (Table 1) . 
Scavenging of reactive nitrogen species (RNS)
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) was used as a source of reactive nitrogen species (RNS). An initial screening was performed with all synthesized compounds to select potential candidates able to capture free radicals. The reaction media consisted of an ethanolic solution of DPPH at 100 lM and the Biginelli adduct at 160 lM. Each reaction medium was analyzed at 517 nm after 30 min of incubation under stirring and darkness at 25°C. Resveratrol, a known antioxidant derived from plants, was used as a positive control. The percentage of DPPH radicals scavenged by (thio)urea-derived Biginelli adducts is shown in Figure 2 .
The screening revealed the adducts BA14, BA15, BA22 and BA23 as the best candidates for further studies of DPPH scavenging activity since such DHPMs were as potent as resveratrol ( Fig. 2) . Adducts BA20 and BA21 were also considered promising compounds as they scavenged 65% of DPPH radicals present in the reaction medium. No significant activity was exhibited by other analogs. A phenolic hydroxyl group at para position and oxygenated groups (hydroxyl or methoxyl) at meta position in the aromatic ring (Table  1 ) contributed relevantly to the RNS scavenging activity of BA14, BA15, BA22 and BA23. The absence of second methoxyl group at meta position diminished at some degree the adducts potency as attested by the results obtained for BA20 and BA21. In general, thiourea-derived Biginelli adducts ( Fig. 2B ) seemed to be more effective than the corresponding oxo-analogs ( Fig. 2A ) in sequestering DPPH radicals. These results prompted us to further investigate the concentration of adducts BA14, BA20 and BA22 (oxo-derivatives) and BA15, BA21 and BA23 (thio-derivatives) necessary to scavenge 50% of DPPH radicals (SC 50 ) present in the reaction medium. A linear behavior of DPPH scavenging was observed when the DHPMs were used at concentrations up to 40 lM, with exception of BA20 and BA21 ( Fig. S1 , Supplementary data). The Biginelli adducts BA14, BA15, BA22 and BA23 presented SC 50 values lower than that of resveratrol ( Table 2) . Adducts BA20 and BA21, however, were about 4-fold less potent than BA14, BA15, BA22 and BA23. Moreover, these last four adducts were 37-to 40-fold more potent in scavenging DPPH radicals than the monastrol (BA2) analogs reported elsewhere. 8 A kinetic study was then performed with BA14, BA15, BA22 and BA23 at the corresponding SC 50 . In the first minutes of reaction, the tested Biginelli adducts were more efficient in scavenging DPPH radicals than was resveratrol ( Fig. 3 ). The adduct BA14 was twice as effective as resveratrol after the first minute in contact with DPPH radicals. The capture of DPPH radicals was linear up to the third minute of reaction for all adducts tested, from which a plateau was reached. In contrast, DPPH scavenging by resveratrol was almost constant along with 10 min of reaction ( Fig. 3) , which resulted in failure to determining the scavenging velocity. The urea-derivatives BA14 and BA22 were able to scavenge 488.5 ± 14.5 and 527.3 ± 25.7 pmol of DPPH/min, respectively, while the thiourea-derivatives BA15 and BA23 sequestered 412.8 ± 23.8 and 369.8 ± 6.4 pmol of DPPH/min, respectively ( Fig. 3 ). Thus, oxo-derived Biginelli adducts were faster than the corresponding thio-analogs in the scavenging of DPPH radicals. Combined, these results indicate the great potential of BA14, BA15, BA22 and BA23 to scavenge RNS. 
Scavenging of reactive oxygen species (ROS)
The ability of Biginelli adducts BA14, BA15, BA22 and BA23 to scavenge ROS was also investigated. The profile of Á O 2 À scavenging as a function of Biginelli adducts concentration is presented in Figure  4 . Resveratrol scavenged Á O 2 À in a concentration-dependent manner. The scavenging of Á O 2 À was linear when Biginelli adducts were employed at concentrations up to 50 lM, except for BA22. The (Fig. 4) . Then, the thio-derived Biginelli adducts were more effective than the corresponding oxo-derivatives.
Antiproliferative activities
Since the disclosure of monastrol (BA2) effect on cancer cells, only few works explored the potential of BA2 analogs. 9, 21, 22 Based on this, the effect of a series of synthesized Biginelli adducts (0.25-250 lg/mL) were investigated on glioma (U251), adriamycin-resistant ovarian cancer (NCI-ADR/RES), kidney cancer (786-0), lung non-small cancer (NCI-H460), prostate cancer (PC-3), ovarian cancer (OVCAR-03) and colon cancer (HT-29) cells. Cell proliferation was determined by the sulforhodamine B method and doxorubicin used as a positive control. 23 The concentration of Biginelli adducts that elicited the inhibition of cell growth by 50% (GI 50 ) is summarized in Table 3 .
U251, NCI-ADR/RES, PC-3 and OVCAR-03 were the most sensitive cancer cells as attested by the number of Biginelli compounds that negatively affected cells growth at GI 50 6 10 lg/mL (Table 3) .
HT-29 cells were the least sensitive to the tested adducts (Table 3) . Adducts BA14 and BA23 were the most active compounds against U251 cells (GI 50 <1 lg/mL). BA11, BA13, BA20, BA24 and BA25 were also promising against U251 cells by exhibiting GI 50 around 5 lg/mL (Table 3 ). BA20 was roughly as potent as doxorubicin against NCI-ADR/RES cells. Biginelli compounds BA11, BA14, BA16, BA17, BA24 and BA28 were also effective on NCI-ADR/RES cells by presenting GI 50 between 2 and 6 lg/mL. BA33 was the most potent adduct against PC-3 cells; its GI 50 value was found to be in the same order of magnitude of that for doxorubicin ( Table 3 ). PC-3 cells were also sensitive to BA2, BA17, BA19, BA24, BA28 and BA29. OVCAR-03 cells were highly sensitive to BA13, BA14, BA16, BA17, BA19, BA20, BA23-25 and BA33 (Table 3) . Compounds BA2, BA24, BA25 and BA33 compromised 786-0 cells growth by 50% when used at concentrations lower than 6 lg/mL while NCI-H460 cells were sensitive to three adducts (BA2, BA24 and BA33). Only 786-0, NCI-H460 and PC-3 cells were sensitive to monastrol (BA2), a known anticancer agent, at a concentration lower than 10 lg/mL. Interestingly, the adduct BA33 was 12-fold more potent than monastrol against PC-3 cells while BA24 and BA33 were threefold more potent on NCI-H460 cells ( Table 3) . Among the tested compounds, BA24 exhibited a large spectrum of action affecting all the cell lines at concentrations lower than 10 lg/mL (Table 3 ). The Biginelli adducts in this study were more active against cancer cells than those previously reported by Russowsky et al. 21 Overall, the potency of Biginelli adducts was dependent on the histological origin of cancer cells.
Conclusion
The potential to scavenge reactive nitrogen/oxygen species (RNS and ROS) and the ability to inhibit the growth of cancer cells were investigated for 26 Biginelli adducts. Among them, BA14, BA15, BA22 and BA23 were found to be promising RNS and ROS scavengers, being indeed more potent than the known antioxidant agent resveratrol. The uncontrolled production of RNS/ROS leads to cellular damages that may result in a series of diseases. 24 Thus, such adducts may be used as lead compounds for the design of effective antioxidant agents. Sixteen monastrol-analogs had their antiproliferative activity against cancer cells evaluated for the first time. The capacity to inhibit cancer cells growth of the Biginelli adducts was dependent on the histological origin of cells. The adduct BA24 was the only exception, being active against all cell lines at concentrations lower than 10 lg/mL. For each cancer cell studied, at least two adducts were more potent than monastrol (BA2). Notably, BA20 and BA33 were as potent and the reference drug doxorubicin against NCI-ADR/RES and PC-3, respectively. These results disclose some monastrol analogs as lead compounds for obtaining new anticancer agents.
Experimental
Chemistry
General procedures
All chemicals were obtained from commercially available sources and used without further purification. Anhydrous conditions were not required for the reaction. Melting points (uncorrected) were determined on Mettler FP 80 HT apparatus. Elemental analyses were performed on CHN Perkin-Elmer 2400 apparatus. Infrared spectra were recorded on Perkin Elmer, Spectrum One spectrophotometer (ATR). 1 H and 13 C NMR spectra were recorded on a Bruker AVANCE DPX-200 spectrometry at 200 MHz and 50 MHz respectively, in DMSO-d 6 .
Synthesis of DHPMs
Aldehydes (3 mmol), ethyl acetoacetate (4.5 mmol) and (thio)urea (4.5 mmol) were dissolved in 3 mL of ethanol containing p-sulfonic acid calix [4] arene (0.5 mol %). The mixture was heated under reflux and stirred for 8 h. 20 The ability of Biginelli adducts BA2 and BA9-BA33 to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, a reactive nitrogen species (RNS), was determined according to Gülcin, 25 with modifications. The screening of potential candidates was done by incubating each compound-test (160 lM) in an ethanolic medium containing 100 lM DPPH. The systems were maintained under stirring and absence of light for 30 min and the absorbance recorded at 517 nm. Those compounds with potential scavenging activity were then tested in the range of 0-160 lM to determine the concentration necessary to scavenge DPPH radicals by 50% (SC 50 ). The best compounds were subjected to kinetic studies at the respective SC 50 values. Results presented are from three independent experiments, each done in triplicate.
Scavenging of reactive oxygen species
The capacity of Biginelli adducts to scavenge superoxide anions ( Á O 2 À ) was evaluated in 50 mM phosphate buffer (pH 7.8) containing 13 mM L-metionine, 75 lM nitroblue tetrazolium, 100 lM EDTA, 2 lM riboflavin and compound-test at 0-200 lM. Reaction mixtures were incubated for 10 min at 25°C in the presence of fluorescent light to induce Á O 2 À formation. Controls consisted of reaction mixtures kept at 25°C for 10 min in absence of light. The percentage of Á O 2 À scavenged by each compound-test was determined through spectrophotometric analysis at 575 nm. Results presented are from three independent experiments, each done in triplicate.
Antiproliferative assay
Human tumor cell lines U251 (glioma), NCI-ADR/RES (multiple drugs-resistant ovarian), 786-0 (renal), NCI-H460 (lung, non-small cells), PC-3 (prostate), OVCAR-03 (ovarian) and HT-29 (colon) were kindly provided by Frederick Cancer Research & Development Center-National Cancer Institute-Frederick, MA, USA. Stock cultures were grown in RPMI 1640 (GIBCO BRL, Life Technologies) supplemented with 5% of fetal bovine serum and penicillin (final concentration of 1 mg/mL) and streptomycin (final concentration of 200 U/mL). [26] [27] [28] Cells in 96-well plates (100 lL cells/well) were exposed to Biginelli adducts (0.25-250 lg/mL) for 48 h at 37°C and 5% of CO 2 . Afterward cells were fixed with 50% trichloroacetic acid, submitted to sulforhodamine B assay for cell proliferation quantitation at 540 nm. 23 The concentration of compound that inhibits cell growth by 50% (GI 50 ) was determined through non-linear regression analysis using software ORIGIN 7.5 (OriginLab Corporation). Doxorubicin was used as a reference drug. Results presented are from two independent experiments, each done in triplicate. Superior (CAPES). Ângelo de Fátima and Luzia Valentina Modolo are supported by research fellowships from CNPq.
